-
Mashup Score: 2Strength Through Inspiration: A Virtual Support Group for Multiple Myeloma Patients & Caregivers who have Young Children - 1 year(s) ago
Feb 14, 2023MM Familes Monthly MeetingFebruary 14, 2023 12:00 pm to 1:00 pm EST Jan 10, 2023MM Familes Monthly MeetingJanuary 10, 2023 12:00 pm to 1:00 pm EST Dec 13, 2022MM Familes Monthly MeetingDecember 13, 2022 12:00 pm to 1:00 pm EST Nov 08, 2022MM Familes Monthly MeetingNovember 8, 2022 12:00 pm to 1:00 pm EST Oct 11, 2022MM Familes Monthly MeetingOctober 11, 2022 12:00 pm to 1:00 pm…
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Clothing - 1 year(s) ago
The International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1MRD2STOP: Can multimodal MRD negativity guide discontinuation of maintenance treatment in myeloma? - 1 year(s) ago
Dr. Ben Derman of the University of Chicago presents a report on the prospective MRD2STOP study investigating sustained multimodal MRD-negativity in patients who discontinue maintenance therapy after meeting per-protocol eligibility criteria for the absence of residual disease.
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Impact of COVID-19 on treatment patterns and management of multiple myeloma: Insights from the Connect® MM Registry - 1 year(s) ago
Dr. Joshua Richter, Mount Sinai Hospital, presents the results of pandemic’s influence on multiple myeloma management, treatment patterns, and provider contact with patients based from insights from the Connect® MM Registry.
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Myeloma Treatment Options in Early Relapse - 1 year(s) ago
These are very exciting times in myeloma – so many new therapies being developed, new drug combinations being used in frontline therapy, new imaging and diagnostic techniques, and so much more!
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Best of 2022 ASCO & EHA Webinar - 2 year(s) ago
Dr. Brian G.M. Durie discusses findings from 2022 American Society of Clinical Oncology (ASCO) meeting and the European Hematology Association’s (EHA) meeting, on such topics as immune therapies, high-risk myeloma, and imaging.
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0The International Myeloma Foundation (IMF) Honors 2022 Research Achievement Awardees, Dr. Hervé Avet-Loiseau and Dr. Bruno Paiva - 2 year(s) ago
LOS ANGELES, CA, JUNE 8, 2022—The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award, which will be presented in an in-person awards ceremony today, June 8th, at the 13th Annual International Myeloma Working Group (IMWG) Summit in Vienna, Austria. Due to COVID-19…
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Health-related Quality of Life in RRMM Patients Treated with Ide-Cel vs Belantamab Mafodotin - 2 year(s) ago
Matching-Adjusted Indirect Comparison Study: Health-related Quality of Life in RRMM Patients Treated with Ide-Cel vs Belantamab Mafodotin Presented at EHA 2022 Dr.Nina Shah Discusses Health-related Quality of Life in RRMM Patients Treated with Idecabtagene Vicleucel (Ide-Cel) vs Belantamab Mafodotin in Matching-Adjusted Indirect Comparison Study Abstract Title: Health-related Quality of Life in…
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1IMF Virtual Regional Community Workshop (RCW) - New England - 2 year(s) ago
Saturday June 18, 2022 7:00 AM PT/ 8:00 AM MDT 9:00 AM CT/10:00 AM ET Register Now
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Kyle Lifetime Achievement Award - 2 year(s) ago
Since 2003, the IMF has honored an outstanding physician each year with the Robert A. Kyle Lifetime Achievement Award. The award, named for its first recipient, is presented to an individual whose body of work in the field of multiple myeloma has made significant advances in research, treatment, and care of myeloma patients. Our honorees’ work reflects the words of Dr. William Mayo, founder of…
Source: International Myeloma FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
Thanks, Robin @IMFsupport! I was wrong to think all patient support groups (apart from FB, etc.) were geographically based. Special virtual IMF support group for #MMsm pts with young children 👇 https://t.co/vQFgW908HV Peer support is so invaluable here - thanks @IMFmyeloma! https://t.co/Rbgm4FAAM8 https://t.co/5TpE7cgMlZ